Relatively little is known about regulated glucagon secretion by human islet α cells compared to insulin secretion from cells, despite conclusive evidence of dysfunction in both cell types in diabetes mellitus. Distinct insulin sequences in humans and mice permit in vivo studies of cell regulation after human islet transplantation in immunocompromised mice, whereas identical glucagon sequences prevent analogous in vivo measures of glucagon output from human cells. We used CRISPR/Cas9 genome editing to remove glucagon-encoding codons 2-29 in immunocompromised (NSG) mice, preserving production of other proglucagonderived hormones, like Glucagon-like-peptide 1. These NSG-Glucagon knockout (NSG-GKO) mice had phenotypes associated with glucagon signaling deficits, including hypoglycemia, hyperaminoacidemia, hypoinsulinemia, and islet α cell hyperplasia. NSG-GKO host metabolic and islet phenotypes reverted after human islet transplantation, and human islets retained regulated glucagon and insulin secretion. NSG-GKO mice provide an unprecedented resource to investigate unique, species-specific human α cell regulation in vivo. 3 Pancreatic islet α and β cells play an important role in maintaining euglycemia by secreting peptide hormones in response to glucose and other blood metabolites. In healthy β cells, hyperglycemia triggers insulin secretion, which promotes glucose uptake and glycogenesis or adipogenesis in 'insulin-target' organs. In contrast, α cell glucagon secretion, stimulated by hypoglycemia, amino acids, and autonomic nerve inputs, leads to glucose mobilization by promoting glycogenolysis and gluconeogenesis in 'glucagon-target' organs, like liver 1 . Impaired regulation or output of insulin and glucagon by human β cells and cells underlies development and progression of diabetes mellitus. Thus, intensive efforts are focused on determining the physiological and pathological mechanisms governing human islet α cell and β cell function.Recent studies reveal that human and mouse islet cells have differences in cellular composition, molecular regulation, physiological control, intra-islet cell interactions and other crucial properties 2-5 , motivating increased research focus and resource generation in human islet biology. Transplantation of human islets in immunocompromised mice, like the NOD.Cg-Prkdc scid Il2rg tm1Wjl Sz mice (NSG) strain 6,7 , has emerged as an important strategy for assessing human islet β cell function in vivo [8][9][10] . Unlike distinct human and mouse insulins, the mature glucagon sequence in these species is identical, precluding accurate quantification of circulating human islet-derived glucagon secretion in mice and limiting studies of human α cells in transplantation-based models. Thus, development of immunocompromised mouse strains that permit detection of human glucagon in mice and in vivo studies of transplanted human islet cell function could be transformative by enabling mechanistic analysis under normal and pathophysiological conditions. Genetic targeting to eliminate ...